Ischemic and Non-Ischemic Priapism Guidelines

Diagnosis and Pathophysiology

The American Urological Association recommends that ischemic priapism is characterized by little or no cavernous blood flow with abnormal blood gases, and patients experience significant pain 1, 3, 4
Ischemic priapism results from failure of venous outflow, creating a compartment syndrome-like condition, and is a true urologic emergency requiring immediate evaluation and treatment 1, 3, 4
Non-ischemic priapism is caused by unregulated cavernous arterial inflow, most commonly from perineal or genital trauma, and is not a medical emergency 2, 4, 6

The American Urological Association suggests that initial management of ischemic priapism is corporal blood aspiration followed by intracavernosal phenylephrine, with a success rate of 43-81% when combined with aspiration 1, 3
For non-ischemic priapism, initial management is conservative observation, and treatment must be based on patient objectives, available resources, and clinician experience 2, 6
For stuttering priapism, the primary goal is preventing future episodes, and patients may be counseled to self-administer intracavernosal phenylephrine at home for episodes not yet meeting 4-hour criteria 2, 4

Patients with sickle cell disease presenting with ischemic priapism should receive immediate urologic intracavernosal treatment as primary therapy, with concurrent systemic sickle cell interventions 3, 5, 7

Corporal blood gas is the gold standard for differentiating types of priapism and should be obtained at initial presentation, and penile duplex Doppler ultrasound may be used when diagnosis is indeterminate 1, 3